Hochman David P 4
4 · Orchestra BioMed Holdings, Inc. · Filed Jun 12, 2026
Research Summary
AI-generated summary of this filing
Orchestra BioMed (OBIO) CEO David Hochman Withholds Shares for Taxes
What Happened
David P. Hochman, Chief Executive Officer and Chairperson of Orchestra BioMed (OBIO), had a total of 6,566 restricted stock unit (RSU) shares withheld by the issuer to satisfy tax withholding obligations associated with RSU vesting. The withholding was recorded as two dispositions of 3,283 shares each at $4.02 per share, for an aggregate value of $26,396. This was a withholding to cover taxes—not an open‑market sale.
Key Details
- Transaction date: June 10, 2026 (reported on Form 4 filed June 12, 2026; timely filing)
- Price per share: $4.02
- Shares withheld/disposed: 3,283 + 3,283 = 6,566 shares
- Aggregate value: $13,198 + $13,198 = $26,396
- Shares owned after transaction: Not specified in this filing
- Footnote: Issuer withheld shares to satisfy tax withholding on RSU vesting; no market sale occurred
Context
Withholding shares to cover taxes on vested RSUs is a routine administrative action and does not necessarily indicate a change in the insider’s view of the company. This transaction reflects compensation tax settlement rather than a deliberate liquidity event or market sale.
Insider Transaction Report
- Tax Payment
Common Stock, par value $0.0001 per share ("Common Stock")
[F1]2026-06-10$4.02/sh−3,283$13,198→ 1,060,746 total - Tax Payment
Common Stock
[F1]2026-06-10$4.02/sh−3,283$13,198→ 436,199 total(indirect: By Trust)
- 2,000(indirect: By Trust)
Common Stock
- 2,000(indirect: By Trust)
Common Stock
- 2,000(indirect: By Trust)
Common Stock
- 3,140(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.